AIM OF THE STUDY: Comparative cross-sectional study of retinal parameters in Huntington's disease and their evaluation as marker of disease progression. CLINICAL RATIONALE FOR THE STUDY: Huntington's disease (HD) is a neurodegenerative disorder with dominant motor and neuropsychiatric symptoms. Involvement of sensory functions in HD has been investigated, however studies of retinal pathology are incongruent. Effect sizes of previous findings were not published. OCT data of the subjects in previous studies have not been published. Additional examination of structural and functional parameters of retina in larger sample of patients with HD is warranted. MATERIALS AND METHODS: This is a prospective cross-sectional study that included: peripapillary retinal nerve fiber layer thickness (RNFL) and total macular volume (TMV) measured by spectral domain optical coherence tomography (OCT) of retina, Pelli-Robson Contrast Sensitivity test, Farnsworth 15 Hue Color discrimination test, ophthalmology examination and Unified Huntington's disease Rating Scale (UHDRS). Ninety-four eyes of 41 HD patients examined in total 47 visits and 82 eyes of 41 healthy controls (HC) examined in total 41 visits were included. Analyses were performed by repeated measures linear mixed effects model with age and gender as covariates. False discovery rate was corrected by Benjamini-Hochberg procedure. RESULTS: HD group included 21 males and 20 females (age 50.6±12.0 years [mean ± standard deviation], disease duration 7.1±3.6 years, CAG triplet repeats 44.1±2.4). UHDRS Total Motor Score (TMS) was 30.0±12.3 and Total Functional Capacity 8.2±3.2. Control group (HC) included 19 males and 22 females with age 48.2±10.3 years. There was no statistically significant difference between HD and HC in age. The effect of the disease was not significant in temporal segment RNFL thickness. It was significant in the mean RNFL thickness and TMV, however not passing false discovery rate adjustment and with small effect size. In the HD group, the effect of disease duration and TMS was not significant. The Contrast Sensitivity test in HD was within normal limits and the 15-hue-test in HD did not reveal any specific pathology. CONCLUSIONS: The results of our study support possible diffuse retinal changes in global RNFL layer and in macula in Huntington's disease, however, these changes are small and not suitable as a biomarker for disease progression. We found no other structural or functional changes in retina of Huntington's disease patients using RNFL layer and macular volume spectral domain OCT and Contrast Sensitivity Test and 15-hue-test. CLINICAL IMPLICATIONS: Current retinal parameters are not appropriate for monitoring HD disease progression.

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Neurology Regional Hospital Pardubice Pardubice Czech Republic

Department of Ophthalmology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

See more in PubMed

Helmlinger D, Yvert G, Picaud S, Merienne K, Sahel J, Mandel JL, et al.. Progressive retinal degeneration and dysfunction in R6 Huntington’s disease mice. Human Molecular Genetnetics 2002; 11(26): 3351–3359. doi: 10.1093/hmg/11.26.3351 PubMed DOI

Johnson M, Gelderblom H, Rüther K, Priller J, Bernstein SL. Evidence that Huntington’s disease affects retinal structure and function. Investigative Ophtalmology & Visual Science 2014; Vol. 55, 1644.

Oepen G, Doerr M, Thoden U. Visual (VEP) and somatosensory (SSEP) evoked potentials in Huntington’s chorea. Electroencephalography and Clinical Neurophysiology 1981; 51(6): 666–670. doi: 10.1016/0013-4694(81)90211-x PubMed DOI

Paulus W, Schwarz G, Werner A, Lange H, Bayer A, Hofschuster M, et al.. Impairment of retinal increment thresholds in Huntington’s disease. Annals of Neurology 1993; 34(4): 574–578. doi: 10.1002/ana.410340411 PubMed DOI

Büttner T, Schulz S, Kuhn W, Blumenschein A, Przuntek H. Impaired colour discrimination in Huntington’s disease. European Journal of Neurology 1994; 1(2), 153–157. doi: 10.1111/j.1468-1331.1994.tb00064.x PubMed DOI

OʼDonnell BF, Blekher TM, Weaver M, White KM, Marshall J et al.. Visual perception in prediagnostic and early stage Huntington’s disease. Journal of the International Neuropsychological Society 2008; 14(3): 446–453. doi: 10.1017/S1355617708080405 PubMed DOI PMC

Kersten HM, Danesh-Meyer HV, Kilfoyle DH, Roxburgh RH. Optical coherence tomography findings in Huntington’s disease: a potential biomarker of disease progression. Journal of Neurology. 2015; 262(11): 2457–2465. doi: 10.1007/s00415-015-7869-2 PubMed DOI

Haider S, Raftopoulos R, Kapoor R, Tabrizi SJ. Macular volume loss in Huntington’s disease on optical coherence tomography—A pilot biomarker study. Journal of Neurology Neurosurgery & Psychiatry 2014; 85: A46–A47. 10.1136/jnnp-2014-309032.132 DOI

Gatto Emilia, Parisi Virginia, Persi Gabriel, Estela Fernandez Rey Martin Cesarini, José Luis Etcheverry, et al (2018) Optical coherence tomography (OCT) study in Argentinean Huntington’s disease patients, International Journal of Neuroscience, 128:12, 1157–1162, doi: 10.1080/00207454.2018.1489807 PubMed DOI

Andrade C, Beato J, Monteiro A, Costa A, Penas S, Guimarães J, et al.. Spectral-domain optical coherence tomography as a potential biomarker in Huntington’s disease. Movement Disorders 2016; 31(3): 377–383. doi: 10.1002/mds.26486 PubMed DOI

Di Maio L.G., Montorio D., Peluso S. et al. Optical coherence tomography angiography findings in Huntington’s disease. Neurol Sci 42, 995–1001 (2021). doi: 10.1007/s10072-020-04611-2 PubMed DOI

Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 2009; 42(2): 377–81. doi: 10.1016/j.jbi.2008.08.010 PubMed DOI PMC

Travis EO. Python for Scientific Computing. Computing in Science and Engineering 2007; 9(3): 10–20. 10.1109/MCSE.2007.58 DOI

Kuznetsova A, Brockhoff PB, Christensen RHB (2017). “lmerTest Package: Tests in Linear Mixed Effects Models.” Journal of Statistical Software, 82(13), 1–26. doi: 10.18637/jss.v082.i13 DOI

Ben-Shachar MS, Lüdecke D, Makowski D (2020). “effectsize: Estimation of Effect Size Indices and Standardized Parameters.” Journal of Open Source Software, 5(56), 2815. doi: 10.21105/joss.02815, 10.21105/joss.02815 DOI

Adhi M, Aziz S, Muhammad K, Mohammad, Adhi I, Li T. Macular Thickness by Age and Gender in Healthy Eyes Using Spectral Domain Optical Coherence Tomography. PLoS ONE. 2012, 7(5) doi: 10.1371/journal.pone.0037638 PubMed DOI PMC